Tailored Multi-Target Agents: Applications and Design Considerations
- Autores
- Talevi, Alan
- Año de publicación
- 2016
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- In contrast to the one target-one drug model, multi-target agents seem as a promising alternative to manage complex disorders and health conditions linked to drug resistance issues. In fact, many longstanding drugs are in fact unintended multi-functional therapeutics that have emerged from phenotypic models. The last two decades, however, have witnessed the emergence of tailored multi-target agents, which according to our perspective combine the best aspects of target-based and phenotypic-based drug discovery. Here we discuss a number of considerations related to the design, screening and computer-aided discovery of multi-targeted drugs, along with neglected advantages that this type of agents might have in clinical trials.
Fil: Talevi, Alan. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
Tailored Multi-Target Agents
Virtual Screening
Drug Design
In Silico Screening
Binding Efficiency Metrics
Drug Resistance
Network Pharmacology - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/54278
Ver los metadatos del registro completo
id |
CONICETDig_99084f7857c6502369d54dd01156c9ba |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/54278 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Tailored Multi-Target Agents: Applications and Design ConsiderationsTalevi, AlanTailored Multi-Target AgentsVirtual ScreeningDrug DesignIn Silico ScreeningBinding Efficiency MetricsDrug ResistanceNetwork Pharmacologyhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1In contrast to the one target-one drug model, multi-target agents seem as a promising alternative to manage complex disorders and health conditions linked to drug resistance issues. In fact, many longstanding drugs are in fact unintended multi-functional therapeutics that have emerged from phenotypic models. The last two decades, however, have witnessed the emergence of tailored multi-target agents, which according to our perspective combine the best aspects of target-based and phenotypic-based drug discovery. Here we discuss a number of considerations related to the design, screening and computer-aided discovery of multi-targeted drugs, along with neglected advantages that this type of agents might have in clinical trials.Fil: Talevi, Alan. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaBentham Science Publishers2016-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/54278Talevi, Alan; Tailored Multi-Target Agents: Applications and Design Considerations; Bentham Science Publishers; Current Pharmaceutical Design; 22; 21; 3-2016; 3164-31701381-6128CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.ingentaconnect.com/contentone/ben/cpd/2016/00000022/00000021/art00008info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:52:43Zoai:ri.conicet.gov.ar:11336/54278instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:52:43.481CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Tailored Multi-Target Agents: Applications and Design Considerations |
title |
Tailored Multi-Target Agents: Applications and Design Considerations |
spellingShingle |
Tailored Multi-Target Agents: Applications and Design Considerations Talevi, Alan Tailored Multi-Target Agents Virtual Screening Drug Design In Silico Screening Binding Efficiency Metrics Drug Resistance Network Pharmacology |
title_short |
Tailored Multi-Target Agents: Applications and Design Considerations |
title_full |
Tailored Multi-Target Agents: Applications and Design Considerations |
title_fullStr |
Tailored Multi-Target Agents: Applications and Design Considerations |
title_full_unstemmed |
Tailored Multi-Target Agents: Applications and Design Considerations |
title_sort |
Tailored Multi-Target Agents: Applications and Design Considerations |
dc.creator.none.fl_str_mv |
Talevi, Alan |
author |
Talevi, Alan |
author_facet |
Talevi, Alan |
author_role |
author |
dc.subject.none.fl_str_mv |
Tailored Multi-Target Agents Virtual Screening Drug Design In Silico Screening Binding Efficiency Metrics Drug Resistance Network Pharmacology |
topic |
Tailored Multi-Target Agents Virtual Screening Drug Design In Silico Screening Binding Efficiency Metrics Drug Resistance Network Pharmacology |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
In contrast to the one target-one drug model, multi-target agents seem as a promising alternative to manage complex disorders and health conditions linked to drug resistance issues. In fact, many longstanding drugs are in fact unintended multi-functional therapeutics that have emerged from phenotypic models. The last two decades, however, have witnessed the emergence of tailored multi-target agents, which according to our perspective combine the best aspects of target-based and phenotypic-based drug discovery. Here we discuss a number of considerations related to the design, screening and computer-aided discovery of multi-targeted drugs, along with neglected advantages that this type of agents might have in clinical trials. Fil: Talevi, Alan. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
In contrast to the one target-one drug model, multi-target agents seem as a promising alternative to manage complex disorders and health conditions linked to drug resistance issues. In fact, many longstanding drugs are in fact unintended multi-functional therapeutics that have emerged from phenotypic models. The last two decades, however, have witnessed the emergence of tailored multi-target agents, which according to our perspective combine the best aspects of target-based and phenotypic-based drug discovery. Here we discuss a number of considerations related to the design, screening and computer-aided discovery of multi-targeted drugs, along with neglected advantages that this type of agents might have in clinical trials. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/54278 Talevi, Alan; Tailored Multi-Target Agents: Applications and Design Considerations; Bentham Science Publishers; Current Pharmaceutical Design; 22; 21; 3-2016; 3164-3170 1381-6128 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/54278 |
identifier_str_mv |
Talevi, Alan; Tailored Multi-Target Agents: Applications and Design Considerations; Bentham Science Publishers; Current Pharmaceutical Design; 22; 21; 3-2016; 3164-3170 1381-6128 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.ingentaconnect.com/contentone/ben/cpd/2016/00000022/00000021/art00008 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Bentham Science Publishers |
publisher.none.fl_str_mv |
Bentham Science Publishers |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613615462645760 |
score |
13.070432 |